Full text is available at the source.
BMAL1-mediated transcriptional regulation of CYP3A13 drives circadian rhythms in intestinal first-pass metabolism
How BMAL1 controls CYP3A13 to create daily rhythms in gut drug processing
AI simplified
Abstract
CYP3A13 expression is significantly higher during the night compared to the day.
- The CYP3A family is primarily expressed in the jejunum, with CYP3A13 being the most prevalent isoform.
- CYP3A13 exhibits a robust circadian rhythm in expression and metabolic activity.
- The circadian clock gene Bmal1 is associated with the regulation of CYP3A13 expression and function.
- Bmal1 directly activates CYP3A13 by binding to an E-box element, as shown through luciferase reporter assays and chromatin immunoprecipitation (ChIP).
- The findings suggest that circadian rhythms may influence the metabolism of orally administered drugs like verapamil.
AI simplified